ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "body mass"

  • Abstract Number: 1508 • 2018 ACR/ARHP Annual Meeting

    Relationship between BMI and Lower Limb Dysfunction in Japanese Female Patients with Rheumatoid Arthritis (the data from NinJa registry)

    Toshihiro Matsui1, Atsushi Hashimoto1, Kimio Masuda2 and Shigeto Tohma3, 1Rheumatology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan, 2Department of Rehabilitation Medicine, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan, 3National Hospital Organization Tokyo Hospital, Sagamihara, Japan

    Background/Purpose: To clarify the relationship between Body Mass Index (BMI) and lower limb dysfunction in patients with rheumatoid arthritis (RA). Methods: The data of 8,332…
  • Abstract Number: 2314 • 2018 ACR/ARHP Annual Meeting

    Ratio of BMI to BMD at Different Sites and Association with Fragility Fractures

    Marco Massarotti1 and Marwan Bukhari2, 1Rheumatology, Royal Lancaster Infirmary, University Hospital of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, 2Lancaster Medical School, Lancaster University, Lancaster, United Kingdom

    Background/Purpose:   Low body mass index (BMI)is linked to increase risk for osteoporosis , and fragility fractures and is therefore included in most fracture prediction…
  • Abstract Number: 2325 • 2018 ACR/ARHP Annual Meeting

    Sex Differences in the Association of Frailty and Bone Mineral Density in Patients with Rheumatoid Arthritis

    Katherine D. Wysham1, Dolores M. Shoback2, John B. Imboden Jr.3 and Patricia Katz4, 1University of California, San Francisco, San Francisco, CA, 2Medicine, San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4University of California San Francisco, San Francisco, CA

    Background/Purpose: Frailty in the general population is associated with poor outcomes including osteoporosis (OP), fracture and death. Frailty occurs at a higher rate in RA…
  • Abstract Number: 2188 • 2017 ACR/ARHP Annual Meeting

    Risk of Disability in Underweight Persons with or at Increased Risk of Knee Osteoarthritis

    Nilasha Ghosh, Joan S. Chmiel, Orit Almagor, Karen W. Hayes, Kirsten C. Moisio, Alison H. Chang, Julie Szymaszek and Leena Sharma, Northwestern University, Chicago, IL

    Background/Purpose: US studies have revealed a U-shaped relationship between BMI and poor outcomes (function, mortality); both underweight and overweight/obese persons have greater risk. In knee…
  • Abstract Number: 2204 • 2017 ACR/ARHP Annual Meeting

    Neuropathic Pain in Patients with Knee Osteoarthritis and Related Factors: A Multicenter Longitudinal Study-Preliminary Report

    Ece Kaptanoglu1, Ozlem Şahin2, Tiraje Tuncer3, Sami Hizmetli1, Lale Altan4, Figen Ayhan5, Ajda Bal6, Meral Bilgilisoy7, Gulnur Bozbas8, Lale Cerrahoglu9, Remzi Cevik10, Tuncay Duruoz11, Deniz Dulgeroglu6, Gulcan Gurer12, Savas Gursoy13, Simin Hepguler14, Cahit Kacar15, Taciser Kaya16, Meltem Melikoglu17, Kemal Nas18, Suheda Ozcakir19, Senay Ozdolap20, merih Saridogan21, Selda Sarikaya20, Dilsad Sindel22, Omer F Şendur8, Canan Tikiz23 and Hatice Ugurlu24, 1Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Cumhuriyet University School of Medicine, Sivas, Turkey, 2Department of Physical Medicine and Rehabilitation, Cumhuriyet University School of Medicine, Sivas, Turkey, 3Department of Physical Medicine and Rehabilitation, Akdeniz University School of Medicine, Antalya, Turkey, 4Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Uludag University School of Medicine, Bursa, Turkey, 5Department of Physical Medicine and Rehabilitation, University of Health Ankara Training and Research Hospital, Ankara, Turkey, 6Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey, 7Department of Physical Medicine and Rehabilitation, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey, 8Department of Physical Medicine and Rehabilitation, Adnan Menderes University School of Medicine, Aydin, Turkey, 9Department of Physical Medicine and Rehabilitation, Celal Bayar University School of Medicine, Manisa, Turkey, 10Department of Physical Medicine and Rehabilitation, Dicle University School of Medicine, Diyarbakir, Turkey, 11Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 12Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Adnan Menderes University School of Medicine, Aydin, Turkey, 13Department of Physical Medicine and Rehabilitation, Gaziantep University School of Medicine, Gaziantep, Turkey, 14Department of Physical Medicine and Rehabilitation, Ege University School of Medicine, Izmir, Turkey, 15Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Akdeniz University School of Medicine, Antalya, Turkey, 16Department of Physical Medicine and Rehabilitation, University of Health Sciences İzmir Bozyaka Training and Research Hospital, Izmir, Turkey, 17Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Ataturk University School of Medicine, Erzurum, Turkey, 18Department of Physical Medicine and Rehabilitation, Sakarya University School of Medicine, Sakarya, Turkey, 19Department of Physical Medicine and Rehabilitation, Uludag University School of Medicine, Bursa, Turkey, 20Department of Physical Medicine and Rehabilitation, Bulent Ecevit University School of Medicine, Zonguldak, Turkey, 21Department of Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey, 22Department of Physical Medicine and Rehabilitation, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey, 23Celal Bayar University School of Medicine, Manisa, Turkey, 24Department of Physical Medicine and Rehabilitation, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey

    Background/Purpose: Neuropathic pain (NP) was accused for increased pain and reduced functional capacity in knee osteoarthritis (KO). Here we aimed to find out the prevalence…
  • Abstract Number: 2371 • 2017 ACR/ARHP Annual Meeting

    The Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis Stratified By Baseline Body Mass Index

    Ara Dikranian1, Miguel Angel Gonzalez-Gay2, Frank Wellborne3, Jose Maria Alvaro-Gracia4, Liza Takiya5, Lori Stockert5, Douglass Chapman6, Svitlana Tatulych7, Palle Dahl8 and Jeffrey R. Curtis9, 1Cabrillo Center for Rheumatic Disease, San Diego, CA, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Houston Institute for Clinical Research, Houston, TX, 4Hospital Universitario de La Princesa, IIS Princesa, Madrid, Spain, 5Pfizer Inc, Collegeville, PA, 6Pfizer Inc, New York, NY, 7Pfizer Inc, Groton, CT, 8Pfizer Inc, Ballerup, Denmark, 9University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post-hoc analysis aims to explore the efficacy of tofacitinib…
  • Abstract Number: 2376 • 2017 ACR/ARHP Annual Meeting

    Weight Histories Expose the Systematic Underestimation of the Risks of Obesity on Mortality in Rheumatoid Arthritis

    Joshua Baker1, Bryant R. England2, Ted R. Mikuls3 and Kaleb Michaud4, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, 3Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Emerging evidence suggests that long-term weight loss is an important confounder that results in an underestimation of the risks of obesity in chronic illness.…
  • Abstract Number: 2523 • 2017 ACR/ARHP Annual Meeting

    The Prevalence, Incidence and Associated Factors for Liver Abnormalities in Psoriatic Arthritis:  Resutls from a Longitudinal Observational Cohort

    Rattapol Pakchotanon1, Justine (Yang) Ye1, Richard J. Cook2, Vinod Chandran3 and Dafna D Gladman3, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease which affects the skin and musculoskeletal system. PsA patients frequently suffer from comorbidities: cardiovascular disease, metabolic…
  • Abstract Number: 2961 • 2017 ACR/ARHP Annual Meeting

    Body Composition and Myokine Levels in Juvenile Dermatomyositis and Associations with Physical Function

    Birgit Nomeland Witczak1, Kristin Godang2, Jens Bollerslev2,3, Thomas Schwartz4,5, Berit Flatø3,6, Ivar Sjaastad3,4,7 and Helga Sanner6,8, 1Oslo University Hospital, Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 2Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, 3Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, 4Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 5Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 6Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, 7Department of Cardiology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 8Norwegian National Advisory Unit on Rheumatic Diseases in Children and Adolescents, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway

    Background/Purpose: JDM presents with proximal muscle weakness and atrophy is frequent. Still, body composition (BC) in JDM has not been widely studied, but is known…
  • Abstract Number: 1636 • 2017 ACR/ARHP Annual Meeting

    Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus

    George Stojan1, Wei Fu2 and Michelle Petri3, 1Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD

    Background/Purpose:   Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28…
  • Abstract Number: 1692 • 2017 ACR/ARHP Annual Meeting

    Decreased Lean Body Mass, Body Fat and Bone Mineral Density in Scleroderma Patients Are Associated with Disease Activity and Physical Activity

    Sabina Oreska1, Maja Spiritovic1,2, Petr Cesak2, Michal Cesak2, Hana Storkanova1, Katerina Kubinova1, Martin Klein1, Lucia Vernerova1, Olga Ruzickova1, Herman F Mann3, Karel Pavelka1, Ladislav Senolt1, Jiri Vencovsky1, Radim Becvar1 and Michal Tomcik1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic, 3Experimental and Clinical Rheumatology, Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Systemic sclerosis (SSc) is characterized by fibrosis of the skin and visceral organs, especially digestive tract, and musculoskeletal involvement, which limit mobility/self-sufficiency of patients,…
  • Abstract Number: 1901 • 2017 ACR/ARHP Annual Meeting

    Unfavorable Body Composition Already at the Onset of Clinical Arthritis

    Samina A. Turk1,2, Dirkjan van Schaardenburg3,4, Maarten Boers4,5, Sylvia de Boer1, Cindy Fokker1, Willem F. Lems4,5 and Michael Nurmohamed1,5, 1Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 5Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: An unfavorable body composition is often present in chronic arthritis patients. This unfavorable composition is a loss of muscle mass (sarcopenia), with a stable…
  • Abstract Number: 1954 • 2017 ACR/ARHP Annual Meeting

    Association of CRP with BMI in Males and Females

    Taik Kim1, Stephen J. Ganocy2, Maria Antonelli3, Douglas Einstadter4 and Stanley Ballou1, 1Rheumatology, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH, 3Department of Medicine/Division of Rheumatology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, OH, 4Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: C-reactive Protein (CRP) is an inflammatory marker commonly used to help aid in diagnosis, assess disease activity or monitor response to therapy. It is…
  • Abstract Number: 1961 • 2017 ACR/ARHP Annual Meeting

    Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study

    Ketty Machado1, Diogo S Domiciano2, Luana G Machado3, Jaqueline B Lopes4, Camille P Figueiredo5, Valéria F. Caparbo3, Liliam Takayama3, Paulo Menezes6 and Rosa M R Pereira2, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division, Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 5Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 6Preventive medicine, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Sarcopenia is a syndrome characterized by progressive loss of skeletal muscle mass, which results in decreased muscle strength and impairment of functional capacity. Moreover,…
  • Abstract Number: 2153 • 2017 ACR/ARHP Annual Meeting

    Decreased Lean Body Mass and Bone Mineral Density but Increased Body Fat in Myositis Patients Are Associated with Disease Duration, Inflammatory Status, Skeletal Muscle Involvement and Physical Activity

    Sabina Oreska1, Maja Spiritovic1,2, Petr Cesak2, Ondrej Marecek2, Hana Storkanova1, Katerina Kubinova1, Martin Klein1, Lucia Vernerova1, Olga Ruzickova1, Radim Becvar1, Karel Pavelka1, Ladislav Senolt1, Herman F Mann1, Jiri Vencovsky1 and Michal Tomcik1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are characterized by inflammation and atrophy of skeletal muscles, pulmonary and articular involvement, which limit the mobility/self-sufficiency of patients, and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology